$10.90+0.02 (+0.18%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Neogen (NEOG) Institutional Ownership
13F filers reported holding 27.0% of Neogen (NEOG) shares as of Sep 30, 2026, across 178 filers.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
- Held by 13F filers
- 27.0%
- Sep 30, 2026
- 13F filers
- 178
- quarter ended Sep 30, 2026
- 13F value
- $754.9M
- 59.0M shares
- Quarter's fund flow
- Mild accumulation
- 25 new · 17 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
13F fund flowQuarter ended Sep 30, 2026*: more funds added or entered than trimmed or exited, mild accumulation (25 new · 52 increased · 58 reduced · 17 closed · 26 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 178 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Yarwood Jeremy | Chief Scientific Officer | Disposed · Open-market sale | 9,051 | $12.67 | ↗ |
| Nov 3, 2026 | Yarwood Jeremy | Chief Scientific Officer | Acquired · Option exercise | 16,207 | $11.82 | ↗ |
| Nov 3, 2026 | Yarwood Jeremy | Chief Scientific Officer | Disposed · Tax withholding | 7,156 | $11.82 | ↗ |
| Nov 2, 2026 | Freels Joe B | Chief Commercial Officer | Acquired · Grant / award | 6,345 | $11.82 | ↗ |
| Nov 2, 2026 | Freels Joe B | Chief Commercial Officer | Acquired · Grant / award | 31,311 | — | ↗ |
| Oct 29, 2026 | Hastings Gregory S | VP, Animal Health | Acquired · Option exercise | 1,211 | $12.21 | ↗ |
| Oct 29, 2026 | Hastings Gregory S | VP, Animal Health | Disposed · Tax withholding | 337 | $12.21 | ↗ |
| Oct 29, 2026 | Hastings Gregory S | VP, Animal Health | Disposed · Option exercise | 1,211Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | Woteki Catherine E | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | Woteki Catherine E | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | RODRIGUEZ RAFAEL A | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | RODRIGUEZ RAFAEL A | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | Gupta Aashima | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | Gupta Aashima | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | Green Ronald D | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | Green Ronald D | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | CAPELLO JEFFREY D | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | CAPELLO JEFFREY D | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
| Oct 29, 2026 | BOREL JAMES C | director | Acquired · Option exercise | 1,776 | $12.21 | ↗ |
| Oct 29, 2026 | BOREL JAMES C | director | Disposed · Option exercise | 1,776Restricted Stock Units | $12.21 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Neogen do institutions hold?
13F filers reported holding 27.0% of Neogen's shares as of Sep 30, 2026, across 178 filers.
How many 13F filers hold Neogen?
Neogen was held by 178 13F filers as of Sep 30, 2026.
Not investment advice.

